Michael E. Perlman

2.0k total citations
32 papers, 1.7k citations indexed

About

Michael E. Perlman is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael E. Perlman has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Organic Chemistry and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael E. Perlman's work include Synthesis and Characterization of Heterocyclic Compounds (5 papers), Neuroscience and Neuropharmacology Research (5 papers) and Biochemical and Molecular Research (5 papers). Michael E. Perlman is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (5 papers), Neuroscience and Neuropharmacology Research (5 papers) and Biochemical and Molecular Research (5 papers). Michael E. Perlman collaborates with scholars based in United States, Australia and United Kingdom. Michael E. Perlman's co-authors include Robert E. London, Elizabeth Murphy, Charles Steenbergen, D. G. Davis, Donald G. Davis, John A. Williams, Patricia G. Cosgrove, M J Bamberger, Ronald W. Clark and Thomas Sand and has published in prestigious journals such as Circulation Research, Biochemistry and Annals of the New York Academy of Sciences.

In The Last Decade

Michael E. Perlman

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Perlman United States 16 724 428 313 263 208 32 1.7k
Scott A. Gabel United States 26 1.1k 1.6× 422 1.0× 236 0.8× 93 0.4× 75 0.4× 62 2.4k
Pamela B. Garlick United Kingdom 17 626 0.9× 699 1.6× 617 2.0× 143 0.5× 258 1.2× 47 2.2k
Klaus D. Schnackerz Germany 28 1.3k 1.8× 99 0.2× 234 0.7× 218 0.8× 35 0.2× 99 2.2k
F. Mark H. Jeffrey United States 27 1.4k 2.0× 198 0.5× 382 1.2× 177 0.7× 35 0.2× 44 2.8k
Peter Bast United States 13 428 0.6× 420 1.0× 222 0.7× 60 0.2× 154 0.7× 14 924
R. Potashnik Israel 25 741 1.0× 125 0.3× 101 0.3× 178 0.7× 75 0.4× 48 2.2k
Eric T. Fossel United States 25 857 1.2× 92 0.2× 178 0.6× 97 0.4× 50 0.2× 57 2.0k
R. A. Iles United Kingdom 27 863 1.2× 76 0.2× 66 0.2× 195 0.7× 63 0.3× 105 2.7k
Toichi Takenaka Japan 25 781 1.1× 75 0.2× 356 1.1× 208 0.8× 24 0.1× 106 1.8k
Chung‐Eun Ha United States 21 929 1.3× 49 0.1× 153 0.5× 132 0.5× 18 0.1× 33 1.6k

Countries citing papers authored by Michael E. Perlman

Since Specialization
Citations

This map shows the geographic impact of Michael E. Perlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Perlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Perlman more than expected).

Fields of papers citing papers by Michael E. Perlman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Perlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Perlman. The network helps show where Michael E. Perlman may publish in the future.

Co-authorship network of co-authors of Michael E. Perlman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Perlman. A scholar is included among the top collaborators of Michael E. Perlman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Perlman. Michael E. Perlman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McEvoy, Claire L., Natalie L. Trevaskis, Glenn A. Edwards, et al.. (2014). In vitro–in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623. European Journal of Pharmaceutics and Biopharmaceutics. 88(3). 973–985. 18 indexed citations
2.
Padmanabhan, Seetharamaiyer, Michael E. Perlman, Lu Zhang, et al.. (2001). Identification and characterization of a potential ischemia-selective N-methyl-d-aspartate (NMDA) receptor ion-channel blocker, CNS 5788. Bioorganic & Medicinal Chemistry Letters. 11(4). 501–504. 8 indexed citations
3.
Padmanabhan, Seetharamaiyer, Paresh Thakker, Lu Zhang, et al.. (2001). Solution-Phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers. Bioorganic & Medicinal Chemistry Letters. 11(24). 3151–3155. 10 indexed citations
4.
Owens, Jonathan, Ailsa L. McGregor, Kazuya Kodama, et al.. (2000). Synthesis and binding characteristics of N-(1-naphthyl)-N′-(3-[125I]-iodophenyl)-N′-methylguanidine ([125I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation. Nuclear Medicine and Biology. 27(6). 557–564. 42 indexed citations
5.
Reddy, N. Laxma, Wenhong Fan, Michael E. Perlman, et al.. (1998). Synthesis and Pharmacological Evaluation of N,N‘-Diarylguanidines as Potent Sodium Channel Blockers and Anticonvulsant Agents. Journal of Medicinal Chemistry. 41(17). 3298–3302. 16 indexed citations
6.
Goldin, Stanley M., Rahul Sharma, Andrew Knapp, et al.. (1995). Neuroprotective Use‐Dependent Blockers of Na+ and Ca2+ Channels Controlling Presynaptic Release of Glutamatea. Annals of the New York Academy of Sciences. 765(1). 210–229. 26 indexed citations
7.
Perlman, Michael E., Donald G. Davis, George W. Koszalka, Joel V. Tuttle, & Robert E. London. (1994). Studies of Inhibitor Binding to Escherichia coli Purine Nucleoside Phosphorylase Using the Transferred Nuclear Overhauser Effect and Rotating-Frame Nuclear Overhauser Enhancement. Biochemistry. 33(24). 7547–7559. 19 indexed citations
8.
Davis, D. G., Michael E. Perlman, & Robert E. London. (1994). Direct Measurements of the Dissociation-Rate Constant for Inhibitor-Enzyme Complexes via the T1ρ and T2 (CPMG) Methods. Journal of Magnetic Resonance Series B. 104(3). 266–275. 255 indexed citations
9.
Steenbergen, Charles, Michael E. Perlman, Robert E. London, & Elizabeth Murphy. (1993). Mechanism of preconditioning. Ionic alterations.. Circulation Research. 72(1). 112–125. 292 indexed citations
10.
London, Robert E., Michael E. Perlman, & Donald G. Davis. (1992). Relaxation-matrix analysis of the transferred nuclear overhauser effect for finite exchange rates. Journal of Magnetic Resonance (1969). 97(1). 79–98. 71 indexed citations
11.
Perlman, Michael E., Donald G. Davis, Scott A. Gabel, & Robert E. London. (1990). Uridine diphospho sugars and related hexose phosphates in the liver of hexosamine-treated rats: identification using phosphorus-31-{proton} two-dimensional NMR with HOHAHA relay. Biochemistry. 29(18). 4318–4325. 21 indexed citations
12.
Selinsky, Barry S., Michael E. Perlman, Robert E. London, et al.. (1990). Carbon-13 and nitrogen-15 nuclear magnetic resonance evidence of the ionization state of substrates bound to bovine dihydrofolate reductase. Biochemistry. 29(5). 1290–1296. 23 indexed citations
13.
Selinsky, Barry S., et al.. (1990). Dissociation constants for dihydrofolic acid and dihydrobiopterin and implications for mechanistic models for dihydrofolate reductase. Biochemistry. 29(19). 4554–4560. 45 indexed citations
15.
Perlman, Michael E., K. A. WATANABE, Raymond F. Schinazi, & Jack J. Fox. (1985). ChemInform Abstract: NUCLEOSIDES. 133. SYNTHESIS OF 5‐ALKENYL‐1‐(2‐DEOXY‐2‐FLUORO‐β‐D‐ARABINOFURANOSYL)CYTOSINES AND RELATED PYRIMIDINE NUCLEOSIDES AS POTENTIAL ANTIVIRAL AGENTS. Chemischer Informationsdienst. 16(44). 2 indexed citations
16.
Rose, William C., et al.. (1985). Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents. Journal of Medicinal Chemistry. 28(11). 1685–1691. 5 indexed citations
17.
Perlman, Michael E., Peter S. Conti, Bernard Schmall, & Kyoichi A. Watanabe. (1984). Synthesis and purification of the anti-viral agent 1-(2-deoxy-2-fluoroβ-d-arabinofuranosyl)-5-iodocytosine (FIAC) labeled with iodine-125. International Journal of Nuclear Medicine and Biology. 11(3-4). 215–218. 9 indexed citations
18.
Allen, Christopher W., et al.. (1980). Organophosphazenes. XIV. Para substituted aryl and mixed para substituted aryl/pheyl fluorocyclotriphosphazene derivatives [1]. Inorganica Chimica Acta. 41. 265–269. 4 indexed citations
19.
Bardos, Thomas J., Joseph A. Dunn, & Michael E. Perlman. (1979). Chemical mechanism of the radiation potentiating effects of 2,2-Dimethylaziridine-type antitumor agents. International Journal of Radiation Oncology*Biology*Physics. 5(9). 1653–1656. 5 indexed citations
20.
Hollifield, Guy, Michael E. Perlman, & Walther Parson. (1962). Free fatty acid content of adipose tissuein three types of obese mice during fasting.. PubMed. 11. 117–22. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026